Jubilant Ingrevia growth over the years

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+5.0%−2.8%
EBITDA+9.2%+1.2%
Net Income+10.7%−3.3%
EPS (adj.)+10.7%−3.3%
Total Assets+9.0%+8.8%
Total Equity+6.8%+5.4%
Free Cash Flow+58.1%—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

JUBLINGREA₹604.00

Jubilant Ingrevia Ltd.

· Chemicals
₹ CrorePeersVIDHIINGPARADEEPPCBLFACTOALIGPLPAUSHAKLTDTIRUMALCHMMcap ₹9,543 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+5.0-2.8
EBITDA+9.2+1.2
Net Income+10.7-3.3
EPS (adj.)+10.7-3.3
Total Assets+9.0+8.8
Total Equity+6.8+5.4
Free Cash Flow+58.1—
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.